ọdịnaya
N'ikwekọ na ebumnuche ya, Board Editorial of MedTvoiLokony na-eme mgbalị ọ bụla iji nye ọdịnaya ahụike a pụrụ ịdabere na ya nke ihe ọmụma sayensị kachasị ọhụrụ kwadoro. Ọkọlọtọ agbakwunyere “Ọdịnaya A nyochara” na-egosi na onye dibịa enyochala ma ọ bụ dee ya ozugbo. Nkwenye nzọụkwụ abụọ a: onye nta akụkọ ahụike na dọkịta na-enye anyị ohere ịnye ọdịnaya kachasị elu nke kwekọrọ na ihe ọmụma ahụike ugbu a.
Nkwenye anyị na mpaghara a anabatala nke ọma, n'etiti ndị ọzọ, site n'aka Association of Journalists for Health, nke nyere ndị Editorial Board of MedTvoiLokony aha nsọpụrụ nke Onye Nkụzi Ukwu.
Bioxetin bụ ọgwụ na-egbochi ịda mbà n'obi. Nwere fluoxetine 20 mg n'otu mbadamba. A na-ere ya na ngwugwu iri atọ. Ọ bụ ọgwụ ndị National Health Fund kwụrụ.
Kedu ka Bioxetin si arụ ọrụ yana otu esi eji ya?
Ihe na-arụ ọrụ nke nkwadebe Bioxetine e fluoxetine. Ihe a bụ nke otu ọgwụ a na-akpọ SSRIs - ndị na-emechi ihe nchịkwa serotonin na-ahọrọ. Serotonin, nke a na-akpọkarị hormone obi ụtọ, bụ neurotransmitter nke ụkọ ya nwere ike ịkpata ịda mbà n'obi, ike ọgwụgwụ ma ọ bụ iwe. Fluoxetine na-arụ ọrụ inter alia, site na igbochi serotonin transporter (SERT). N'ihi usoro ya omume bụ ọgwụ -ABỤ na nsogbu ndị dị ka: akụkụ nke nnukwu ịda mbà n'obi (na ndị ọrịa nwere ịda mbà n'obi leczenie kwesịrị ịdịru ma ọ dịkarịa ala ọnwa 6), nsogbu ndị na-achọsi ike, ya bụ echiche itinye uche, omume mmanye - nke a na-akpọbu dị ka nsogbu mkparị (obsessive compulsive disorder).leczenie opekempe nke izu 10, ma ọ bụrụ na ọ nweghị ọganihu mgbe oge a gasịrị, a ga-atụle mgbanwe na ọgwụ ọzọ), bulimia nervosa - bulimia nervosa - na nke a dị ka ihe mgbakwunye na psychotherapy. Na-emekarị na mbụ ọrịa abụọ metụtara dose ahụ bụ 20 mg - mbadamba 1 kwa ụbọchị, na bulimia nervosa 60 mg - mbadamba 3 kwa ụbọchị, mana dọkịta ga-ahọrọ usoro onunu n'otu n'otu. Onye nrụpụta ebe Bioxetin bụ sanofi-aventis.
Biko mara na mmetụta ọgwụgwọ nwere ike ọ gaghị apụta ruo ọtụtụ izu ka e mesịrị ojiji ọgwụ. Ruo mgbe ahụ, ndị ọrịa kwesịrị ịnọ n'okpuru nlekọta ahụike chiri anya, ọkachasị ma ọ bụrụ na ha nwere nkụda mmụọ ma nwee echiche igbu onwe ha. Mgbe emechara ọgwụgwọ e kwesịghị itinye ya n'akụkụ fluoxetine na mberede ma jiri nwayọọ nwayọọ belata dose ahụ ka ị nwere ike nweta mgbaàmà nkwụsịtụ, tumadi isi ọwụwa na isi ọwụwa, nsogbu ụra, asthenia (adịghị ike), mkpasu iwe ma ọ bụ nchekasị, ọgbụgbọ, ọgbụgbọ, na nsogbu mmetụta.
Contraindications na ịkpachara anya mgbe ị na-ewere Bioxetin
obi tara mmiri ihe mgbochi do ngwa ọgwụ na-enwe mmetụta na-adịghị mma maka ihe na-arụ ọrụ ya ma ọ bụ ihe ọ bụla na-emepụta ihe (nwere lactose).
A naghị atụ aro iji ọgwụ ahụ eme ihe Bioxetine n'oge ime na nwa ara. N'ihi data ezughi oke, ọ ka mma ịghara jiri Bioxetinu nakwa na ụmụaka ruru afọ iri na asatọ.
Ọgwụ a na-emetụta arụmọrụ psychomotor ma nwee ike imebi mmeghachi omume ịnya ụgbọ ala.
Fluoxetine nwere ọtụtụ mmekọrịta ya na ọtụtụ ọgwụ ndị ọzọ, biko jiri nlezianya gụọ mpempe akwụkwọ ahụ ma gwa dọkịta gị ma ọ bụrụ na ị na-aṅụ ọgwụ ọ bụla ọzọ. I kwesịghị ojiji ya na ndị na-egbochi MAO - klas ọzọ nke ọgwụ -ABỤ w ọgwụgwọ ịda mbà n'obi. Ọgwụgwọ fluoxetine Enwere ike ịmalite naanị ụbọchị 14 ka nkwụsị nke MAO inhibitors.
Kpachapụ anya n'ime ọgwụgwọ na fluoxetine ndị ọrịa nwere Akwụkwụ na-adọ, ọrịa shuga, ọrịa obi, ọrịa coagulation ọbara.
Bioxetinedị ka ọgwụ na-arụ ọrụ na usoro ụjọ ahụ, ọ nwere ike ịkpata ọtụtụ mmetụta. Ụfọdụ n'ime ha bụ ihe mgbaàmà nke hypersensitivity, nsogbu eriri afọ, isi ọwụwa na dizziness, nsogbu ụra, nkụ ọnụ. Mgbe ọ bụla ị hụrụ mgbaàmà ọ bụla na-akpasu iwe, ị kwesịrị ịkọrọ ya dọkịta gị.